Genomic landscape in small intestine cancer from real-world data (RWD) of clinical genomic testing. Background: Small bowel adenocarcinoma is a rare malignancy with limited data to support the choice ...

Phase II trials are used to show sufficient preliminary activity of a new treatment (in single-arm designs or randomized screening designs) or to select among treatments with demonstrated activity (in ...